Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
J. Quijano-Campos (Cambridge, United Kingdom), M. Thillai (Cambridge, United Kingdom), M. Bravo-Teijeira (Cambridge, United Kingdom), N. Sekhri (London, United Kingdom), F. Kearl (London, United Kingdom), H. Parfrey (Cambridge, United Kingdom), E. Harris (Cambridge, United Kingdom), K. Harding (Cambridge, United Kingdom), R. Rowe (Cambridge, United Kingdom), J. Sanders (London, United Kingdom). Treatment and management of cardiac sarcoidosis. 1388

Member's Comments

No comment yet.

Related content which might interest you: Management of cardiac sarcoidosis Source: Virtual Congress 2020 – Severe thoracic sarcoidosis : where do we stand ? Year: 2020 Incidence, clinical manifestations and prognosis of cardiac sarcoidosis in patients with pulmonary sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Diagnosis of COPD before cardiac surgery Source: Eur Respir J 2015; 46: 1498-1500 Year: 2015 Assessment of cardiac involvement in patients with sarcoidosis Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases Year: 2011 Cardiac sarcoidosis: screening, diagnosis and treatment Source: International Congress 2019 – State of the art session: Interstitial lung diseases Year: 2019 Established and experimental medical therapy of pulmonary sarcoidosis Source: Eur Respir J 2013; 41: 1424-1438 Year: 2013 Cardiac sarcoidosis Source: Eur Respir Monogr 2022; 96: 142-159 Year: 2022 Impact of diagnostic pitfalls on the management of pulmonary sarcoidosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012 Severe sarcoidosis: clinical features and management Source: Virtual Congress 2021 – Rare lung diseases 2021 Year: 2021 Follow-up and nonpharmacological management of the idiopathic pulmonary fibrosis patient Source: Eur Respir Rev 2011; 20: 114-117 Year: 2011 Timing of cardiac sarcoidosis in patients with sarcoidosis> Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases Year: 2017 Role of infliximab in managing resistant ventricular arrhythmias in sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Pulmonary rehabilitation programme in sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 333s Year: 2005 Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines Source: Eur Respir Rev 2014; 23:193-214 Year: 2014 Pulmonary hypertension associated with sarcoidosis and experience of treatment with pentoxifylline (Vasonite) Source: Eur Respir J 2006; 28: Suppl. 50, 426s Year: 2006 Diagnosis and management of acute pulmonary embolism Source: Annual Congress 2009 - PG18 Practical clinical lessons in pulmonary vascular medicine: a case-based approach Year: 2009 Management of sarcoidosis in clinical practice Source: Eur Respir Rev 2016; 25: 141-150 Year: 2016 Problems of diagnosis of pulmonary sarcoidosis Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases Year: 2020